GO:0034755 iron ion transmembrane transport: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0034755 describes the movement of iron ions across biological membranes via transporters or pores, a process essential for cellular iron homeostasis.
DMT1 (SLC11A2) is the prototypical iron ion transmembrane transporter, mediating ferrous iron uptake in a pH-dependent manner.
ZIP8 and ZIP14 transport iron and other metal ions, linking iron transport to broader metal homeostasis.
Mitochondrial iron accumulation due to PINK1 deficiency highlights the role of iron transport in organellar function and tumorigenesis.
Iron transport is regulated by pH, histidine residues in transmembrane domains, and systemic iron status.
Dysregulated iron transport is implicated in cancer, neurodegeneration, and acute pancreatitis.

Description

Iron is an essential trace element required for oxygen transport, electron transfer, and DNA synthesis, but its redox activity can also generate toxic reactive oxygen species. Therefore, cellular iron levels must be tightly controlled, and the movement of iron across membranes is a central regulatory node. GO:0034755, iron ion transmembrane transport, captures the biological processes that mediate the transfer of iron ions from one side of a membrane to the other via transporters or pores. This term encompasses both high-affinity and low-affinity transport mechanisms, as well as ferrous (Fe2+) and ferric (Fe3+) iron transport. Research into iron ion transmembrane transport has revealed a sophisticated network of transporters, including DMT1 (SLC11A2), ZIP8 (SLC39A8), and ZIP14 (SLC39A14), each with distinct tissue distribution and substrate preferences. These transporters are critical for dietary iron absorption, cellular iron uptake, and intracellular iron distribution. Defects in iron transport are associated with a wide range of pathologies, from anemia to neurodegeneration and cancer. Understanding the molecular mechanisms of iron transport is therefore essential for developing therapeutic strategies targeting iron-related diseases. This article provides a comprehensive overview of GO:0034755, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and experimental approaches. It is intended for researchers seeking to study iron transport in health and disease, and for those designing CRISPR-based models to interrogate gene function in this pathway.

iron ion transmembrane transport At A Glance

GO ID GO:0034755
GO term iron ion transmembrane transport
Ontology biological_process
Synonym ferrous ion transmembrane transport; ferrous iron transmembrane transport; high affinity ferrous ion transmembrane transport; high-affinity ferrous ion transmembrane transport; high-affinity iron ion transmembrane transport; high affinity iron ion transport; high-affinity iron ion transport; iron(2+) transmembrane transport; iron ion membrane transport; low-affinity iron ion transmembrane transport; low affinity iron ion transport; low-affinity iron ion transport; transmembrane iron transport
Major function Transport of iron ions across membranes via transporters or pores
Related transporters DMT1 (SLC11A2), ZIP8 (SLC39A8), ZIP14 (SLC39A14), ferroportin (SLC40A1), transferrin receptor (TFRC)
Regulation pH-dependent, histidine residues in transmembrane domains, systemic iron status
Disease relevance Cancer, neurodegeneration, acute pancreatitis, iron overload disorders

What Is GO:0034755?

GO:0034755, iron ion transmembrane transport, is defined as a process in which an iron ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. This includes the transport of ferrous (Fe2+) and ferric (Fe3+) ions, and encompasses both high-affinity and low-affinity transport systems. The process is fundamental to cellular iron homeostasis and is mediated by specialized membrane proteins that facilitate the passage of iron across lipid bilayers.

Why Is iron ion transmembrane transport Important in Cell Biology?

Iron ion transmembrane transport is vital for maintaining cellular iron homeostasis, which is essential for fundamental processes such as oxygen transport, mitochondrial respiration, and DNA synthesis. Dysregulation of this process leads to iron deficiency or overload, both of which have severe pathological consequences. For example, impaired iron transport can cause anemia, while excessive iron accumulation contributes to oxidative stress and tissue damage, implicated in cancer and neurodegenerative diseases. Understanding the molecular players and regulatory mechanisms of iron transport is therefore critical for developing targeted therapies.
Essential for dietary iron absorption and systemic iron balance.
Critical for mitochondrial iron homeostasis and function.
Implicated in cancer development, including colon tumorigenesis.
Linked to neurodegenerative diseases via iron accumulation.
Plays a role in acute pancreatitis through ion channel crosstalk.
Target for therapies in iron overload disorders and anemia.
Involved in host-pathogen interactions, as pathogens compete for iron.
Affects drug metabolism and toxicity through iron-dependent enzymes.
Modulated by environmental factors such as flavonoids.
Key to understanding metal-ion transport in plants and microorganisms.

What Happens During iron ion transmembrane transport?

Iron Uptake at the Cell Membrane
In simple terms: Iron from outside the cell is brought inside through specialized transporter proteins.
The first step in iron ion transmembrane transport is the recognition and binding of iron ions by membrane transporters. DMT1 (SLC11A2) is a major transporter that mediates the uptake of ferrous iron (Fe2+) into cells, particularly in the duodenum and in erythroid precursor cells. DMT1 functions as a proton-coupled symporter, utilizing the pH gradient across the membrane to drive iron transport. Transferrin-bound iron is also taken up via receptor-mediated endocytosis, where the transferrin receptor (TFRC) binds iron-loaded transferrin and internalizes it. This process is essential for cellular iron acquisition and is tightly regulated by cellular iron needs.
Intracellular Iron Trafficking and Export
In simple terms: Once inside, iron is moved to where it is needed or stored, and excess iron can be exported out of the cell.
After uptake, iron ions are transported across intracellular membranes, such as the endosomal membrane, to reach the cytoplasm or mitochondria. DMT1 also mediates iron export from endosomes into the cytoplasm. Ferroportin (SLC40A1) is the only known iron exporter in mammals, transporting iron from the cytoplasm across the plasma membrane into the bloodstream. This export is critical for systemic iron homeostasis and is regulated by the hormone hepcidin. ZIP8 and ZIP14 also contribute to iron transport across membranes, particularly in the liver and other tissues.
Mitochondrial Iron Transport
In simple terms: Iron must cross the mitochondrial membrane to support energy production and other mitochondrial functions.
Mitochondria require iron for the synthesis of heme and iron-sulfur clusters. Iron is transported into the mitochondrial matrix across the inner membrane by specialized transporters, although the exact mechanisms are still being elucidated. PINK1 deficiency has been shown to facilitate mitochondrial iron accumulation, suggesting a role for PINK1 in regulating mitochondrial iron transport. This accumulation can lead to oxidative stress and contribute to tumorigenesis, as observed in colon cancer models.
Regulation by pH and Histidine Residues
In simple terms: The transport of iron is controlled by the acidity of the environment and specific amino acids in the transporter.
The transport activity of DMT1 is highly dependent on pH, with optimal activity at acidic pH. Two histidine residues in transmembrane domain 6 of DMT1 are critical for pH regulation of transport. These residues are thought to sense protons and induce conformational changes that facilitate iron translocation. This pH dependence ensures that iron uptake occurs primarily in the acidic environment of the duodenum or endosomes.
Metal-Ion Specificity and Competition
In simple terms: Iron transporters can also transport other metals, leading to competition and potential toxicity.
Transporters such as ZIP8 and ZIP14 are not entirely specific for iron; they also transport zinc, manganese, and cadmium. This broad substrate specificity means that these transporters can mediate the uptake of toxic metals, contributing to metal-induced toxicity. Understanding the structural basis of metal selectivity is important for designing inhibitors or modulators of iron transport.

Key Genes Involved in GO:0034755 iron ion transmembrane transport

The following genes encode proteins that directly mediate or regulate iron ion transmembrane transport, as supported by published literature.
GeneMajor RoleResearch Relevance
SLC11A2 (DMT1)Ferrous iron transporter; mediates uptake and endosomal exportpH-dependent transport; mutations cause anemia
SLC39A8 (ZIP8)Transports iron, zinc, manganese, cadmiumMetal-ion homeostasis; implicated in liver and immune function
SLC39A14 (ZIP14)Transports iron, zinc, manganeseSystemic iron metabolism; role in liver and pancreas
SLC40A1 (Ferroportin)Only known mammalian iron exporterSystemic iron export; target of hepcidin
TFRC (Transferrin receptor)Mediates transferrin-bound iron uptakeCellular iron delivery; receptor-mediated endocytosis
PINK1Regulates mitochondrial iron transportMitochondrial iron accumulation; tumorigenesis
HFERegulates hepcidin expression; interacts with TFRCHereditary hemochromatosis
HAMP (Hepcidin)Regulates ferroportin degradationSystemic iron homeostasis
FTH1 (Ferritin heavy chain)Iron storage; ferroxidase activityIron sequestration; oxidative stress protection
FTL (Ferritin light chain)Iron storageIron overload disorders
ACO1 (IRP1)Iron regulatory protein; senses iron levelsPost-transcriptional regulation of iron genes
IREB2 (IRP2)Iron regulatory protein; regulates iron metabolismIron homeostasis; neurodegeneration
STEAP3Ferrireductase; reduces Fe3+ to Fe2+ for DMT1Erythropoiesis; iron uptake
CYBRD1 (DcytB)Ferrireductase in duodenumDietary iron absorption
HEPH (Hephaestin)Ferroxidase; facilitates iron exportIron efflux; intestinal absorption
CP (Ceruloplasmin)Ferroxidase; facilitates iron exportIron homeostasis; neurodegeneration
SLC25A37 (Mitoferrin-1)Mitochondrial iron transporterHeme synthesis; erythropoiesis
SLC25A28 (Mitoferrin-2)Mitochondrial iron transporterIron-sulfur cluster synthesis

How Is iron ion transmembrane transport Regulated?

Iron ion transmembrane transport is regulated at multiple levels to maintain cellular and systemic iron homeostasis. At the cellular level, the iron regulatory proteins IRP1 and IRP2 bind to iron-responsive elements (IREs) in the mRNAs of iron metabolism genes, controlling their translation or stability in response to iron levels. For example, low iron increases IRP binding, stabilizing TFRC mRNA and inhibiting ferritin translation, thereby enhancing iron uptake and reducing storage. At the systemic level, the hormone hepcidin regulates the degradation of ferroportin, the major iron exporter, thus controlling iron release into the bloodstream. Additionally, pH and specific amino acid residues, such as histidines in DMT1, modulate transporter activity. PINK1 has been implicated in mitochondrial iron transport regulation, with its deficiency leading to iron accumulation. Environmental factors, such as flavonoids, can also affect iron transport gene expression.

iron ion transmembrane transport and Human Disease

GeneDisease / BiologyPotential Experimental Model
SLC11A2 (DMT1)Anemia, iron overloadKnockout mouse, patient-derived iPSCs
SLC40A1 (Ferroportin)Ferroportin disease, hemochromatosisKnock-in mouse models
PINK1Colon cancer, Parkinson's diseaseKnockout mouse, colon cancer cell lines
SLC39A8 (ZIP8)Metal-related toxicity, liver diseaseOverexpression in hepatocytes
SLC39A14 (ZIP14)Iron overload, neurodegenerationKnockout zebrafish, mouse models
Iron Transport in Cancer
Dysregulated iron transport is increasingly recognized as a hallmark of cancer. Cancer cells often exhibit increased iron uptake to support rapid proliferation. For instance, PINK1 deficiency leads to mitochondrial iron accumulation, which promotes colon tumorigenesis. This suggests that targeting iron transport pathways could be a therapeutic strategy in cancer. Additionally, iron transporters such as ZIP8 and ZIP14 are implicated in metal-induced carcinogenesis due to their ability to transport toxic metals.
Iron Transport in Neurodegeneration
Iron accumulation in the brain is a common feature of neurodegenerative diseases such as Parkinson's and Alzheimer's. Impaired iron transport across the blood-brain barrier and within neurons can lead to oxidative stress and neuronal death. DMT1 and ferroportin are key players in brain iron homeostasis, and their dysregulation has been linked to neurodegeneration. Mutations in ceruloplasmin, a ferroxidase involved in iron export, cause aceruloplasminemia, characterized by iron accumulation in the brain and other organs.
Iron Transport in Acute Pancreatitis
Recent studies have highlighted the crosstalk between calcium, iron, and copper signals in acute pancreatitis. Ion channels in acinar cells, including those mediating iron transport, may contribute to the pathogenesis of this condition. Understanding how iron transport is altered during pancreatitis could reveal new therapeutic targets.
Iron Transport in Infectious Diseases
Pathogens compete with the host for iron, and host iron transport proteins can influence infection outcomes. For example, the down-regulation of iron/zinc ion transport in Microcystis aeruginosa exposed to flavonoids suggests that environmental factors can modulate iron transport in microorganisms. This has implications for understanding microbial ecology and host-pathogen interactions.

From iron ion transmembrane transport-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of DMT1 affect cellular iron uptake?CRISPR knockout of SLC11A2 in HeLa or Caco-2 cells
How do point mutations in DMT1 histidines affect pH sensitivity?Point mutation knock-in of H267A/H272A in SLC11A2
What is the effect of PINK1 deficiency on mitochondrial iron?PINK1 knockout in colon cancer cells
Can overexpression of ferroportin reduce cellular iron?Overexpression of SLC40A1 in HEK293 cells
Does ZIP14 mediate manganese transport?Knockout of SLC39A14 in mouse liver
How does hepcidin regulate ferroportin degradation?Tagged knock-in of SLC40A1 with degron in hepatocytes

How to Study the iron ion transmembrane transport Process

MethodWhat It MeasuresTypical Application
Radioactive iron uptake assayTransport activityKinetic analysis of DMT1
Calcein-AM fluorescenceLabile iron poolLive-cell imaging of iron transport
RNA-seqGene expression changesTranscriptional response to iron stress
ImmunofluorescenceProtein localizationSubcellular distribution of transporters
CRISPR knockout screenGene function in iron transportIdentification of novel regulators
Western blotProtein expression levelsValidation of knockout or overexpression
ICP-MSTotal elemental iron contentQuantification of cellular iron
Measuring Iron Transport Activity
Iron transport activity can be measured using radioactive iron isotopes (e.g., 55Fe or 59Fe) in uptake or efflux assays. Cells are incubated with radiolabeled iron, and intracellular radioactivity is quantified by scintillation counting. This method allows direct assessment of transport kinetics and regulation. Alternatively, fluorescent iron sensors such as Calcein-AM can be used to monitor labile iron pools in live cells.
Gene Expression Analysis
RNA-seq and qPCR can quantify the expression of iron transport genes under various conditions. For example, the effect of flavonoids on iron/zinc ion transport genes in Microcystis aeruginosa was assessed using transcriptomics. In mammalian cells, changes in SLC11A2, SLC40A1, and other transporters can be monitored to infer regulatory mechanisms.
Protein Localization and Interaction Studies
Immunofluorescence and subcellular fractionation can determine the localization of iron transporters. For instance, DMT1 localizes to endosomes and the plasma membrane. Co-immunoprecipitation and proximity ligation assays can identify interacting partners, such as the interaction between ferroportin and hepcidin.
CRISPR Screening for Iron Transport Regulators
Genome-wide CRISPR knockout screens can identify genes that modulate iron transport. Cells are cultured under iron-limited or iron-rich conditions, and sgRNA libraries are used to select for survival. This approach can uncover novel regulators of iron homeostasis and potential therapeutic targets.

How CRISPR Can Be Used to Study GO:0034755 iron ion transmembrane transport

Knockout

CRISPR knockout of iron transport genes such as SLC11A2, SLC40A1, or PINK1 can reveal their essential roles in cellular iron homeostasis. For example, PINK1 knockout leads to mitochondrial iron accumulation and enhanced tumorigenesis in colon cancer models. Knockout studies are invaluable for dissecting the contribution of individual transporters to iron uptake, export, and distribution.

Point Mutation

Point mutations can be introduced to study specific residues critical for transport activity. For instance, mutating the two histidines in transmembrane domain 6 of DMT1 (H267A and H272A) abolishes pH-dependent regulation of iron transport. Such models help elucidate the molecular mechanism of transport and the impact of disease-associated mutations.

Knock-in

Knock-in of tagged versions of iron transporters, such as GFP- or HA-tagged ferroportin, allows for real-time tracking of protein localization and dynamics. Additionally, knock-in of disease-relevant mutations, such as those found in hereditary hemochromatosis, can model human disease in cell lines or mice.

Overexpression

Overexpression of iron transporters can be used to study gain-of-function effects. For example, overexpression of ZIP14 in hepatocytes can increase iron and zinc uptake, leading to metal overload. Overexpression models are useful for testing whether increased transport activity is sufficient to drive pathological changes.

How EDITGENE Supports iron ion transmembrane transport Research

Researchers studying iron ion transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in iron uptake, export, or distribution. CRISPR-based models provide a robust way to manipulate gene function and observe the consequences on cellular iron homeostasis.
Contact EDITGENE today to design your custom CRISPR model for iron ion transmembrane transport research.

Frequently Asked Questions About iron ion transmembrane transport

GO:0034755 is the Gene Ontology term for iron ion transmembrane transport, defined as the process of moving iron ions across a membrane via transporters or pores.
Key genes include SLC11A2 (DMT1), SLC40A1 (ferroportin), SLC39A8 (ZIP8), SLC39A14 (ZIP14), and TFRC (transferrin receptor).
It is regulated by pH, iron regulatory proteins (IRPs), hepcidin, and specific amino acid residues such as histidines in DMT1.
Diseases include anemia, hemochromatosis, cancer, neurodegeneration, and acute pancreatitis.
DMT1 (SLC11A2) is a proton-coupled ferrous iron transporter that mediates iron uptake in the duodenum and endosomal iron export.
Common methods include radioactive iron uptake assays, fluorescent iron sensors, RNA-seq, and CRISPR knockout screens.
High-affinity transport operates at low iron concentrations and is often mediated by specific transporters like DMT1, while low-affinity transport occurs at higher iron concentrations and may involve different transporters or channels.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in iron transport.
PINK1 regulates mitochondrial iron transport; its deficiency leads to mitochondrial iron accumulation and promotes colon tumorigenesis.
DMT1 transport activity is optimal at acidic pH, and two histidine residues in transmembrane domain 6 are critical for pH sensing.

Conclusion

Iron ion transmembrane transport (GO:0034755) is a fundamental biological process that ensures cellular iron homeostasis. Dysregulation of this process contributes to a variety of diseases, including cancer, neurodegeneration, and iron overload disorders. The identification of key transporters such as DMT1, ferroportin, ZIP8, and ZIP14 has advanced our understanding of iron metabolism, but many questions remain regarding their regulation and interplay. CRISPR-based models offer a powerful approach to interrogate the function of these genes in health and disease. EDITGENE provides comprehensive services to support such research, from knockout and knock-in cell lines to CRISPR library screening and bioinformatics analysis.

References

  1. 1. Yu S et al.. 2023. Down-regulation of iron/zinc ion transport and toxin synthesis in Microcystis aeruginosa exposed to 5,4'-dihydroxyflavone.. J Hazard Mater 460:132396 PMID: 37672994
  2. 2. Arcos M et al.. 2025. PINK1-deficiency facilitates mitochondrial iron accumulation and colon tumorigenesis.. Autophagy 21(4):737-753 PMID: 39512202
  3. 3. Luck AN et al.. 2012. Transferrin-mediated cellular iron delivery.. Curr Top Membr 69:3-35 PMID: 23046645
  4. 4. Lam-Yuk-Tseung S et al.. 2003. Iron transport by Nramp2/DMT1: pH regulation of transport by 2 histidines in transmembrane domain 6.. Blood 101(9):3699-707 PMID: 12522007
  5. 5. Andrews NC. 1999. The iron transporter DMT1.. Int J Biochem Cell Biol 31(10):991-4 PMID: 10582331
  6. 7. Jenkitkasemwong S et al.. 2012. Physiologic implications of metal-ion transport by ZIP14 and ZIP8.. Biometals 25(4):643-55 PMID: 22318508
  7. 8. Wang H et al.. 2024. Ion channels in acinar cells in acute pancreatitis: crosstalk of calcium, iron, and copper signals.. Front Immunol 15:1444272 PMID: 39606246
Contact Us
*
*
*
*
How did you hear about us: